Literature DB >> 26875150

Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.

Mahnur Haider1, Naseema Gangat1, Curtis Hanson2, Ayalew Tefferi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26875150     DOI: 10.1002/ajh.24334

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.

Authors:  L Falchi; H M Kantarjian; S Verstovsek
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

Review 2.  Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.

Authors:  Amy Zhou; Amber Afzal; Stephen T Oh
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

3.  Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

Authors:  V De Stefano; A M Vannucchi; M Ruggeri; F Cervantes; A Alvarez-Larrán; A Iurlo; M L Randi; L Pieri; E Rossi; P Guglielmelli; S Betti; E Elli; M C Finazzi; G Finazzi; E Zetterberg; N Vianelli; G Gaidano; I Nichele; D Cattaneo; M Palova; M H Ellis; E Cacciola; A Tieghi; J C Hernandez-Boluda; E Pungolino; G Specchia; D Rapezzi; A Forcina; C Musolino; A Carobbio; M Griesshammer; T Barbui
Journal:  Blood Cancer J       Date:  2016-11-04       Impact factor: 11.037

4.  Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

Authors:  S Cerquozzi; D Barraco; T Lasho; C Finke; C A Hanson; R P Ketterling; A Pardanani; N Gangat; A Tefferi
Journal:  Blood Cancer J       Date:  2017-12-27       Impact factor: 11.037

5.  [Risk factors for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia].

Authors:  X Han; B B Bai; C J Wang; S Zhao; Y Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.